Quarry LP’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quarry LP’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-77	Closed	-$8.24K	–	2139
2025 Q4	$8.24K	Buy	+77	New	+$8.17K	﹤0.01%	1483
2024 Q1	–	Sell	-1,500	Closed	-$69K	–	1872
2023 Q4	$69K	Buy	+1,500	New	+$47.3K	0.01%	248

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Quarry LP's RYTM Position: Q1 2026 in Review

Quarry LP sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 77 shares — an estimated $8.24K sold.

Quarry LP first reported a position in RYTM in Q4 2023 and held it in 2 quarters. The position peaked at $69K in Q4 2023. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

Quarry LP reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Quarry LP sold 77 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $8.24K.
Quarry LP first reported a position in Rhythm Pharmaceuticals in Q4 2023 and held it in 2 quarters.
Quarry LP's Rhythm Pharmaceuticals position peaked at $69K in Q4 2023.
285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.